Literature DB >> 16767056

The influence of comorbidities and complications on discharge function in stroke rehabilitation inpatients.

G Ferriero1, F Franchignoni, E Benevolo, M Ottonello, M Scocchi, M Xanthi.   

Abstract

AIM: The aims of this prospective study were: 1) to assess the frequency, type and severity of comorbidities (COMs) and complications (COMPLs) in acute stroke patients, according to the weighted comorbidity index (w-CI) of Liu et al. and 2 new indices, respectively COM severity index (COM-SI) and COMPL severity index (COMPL-SI); 2) to separately analyse the interference of COMs and COMPLs with functional status and recovery during stroke rehabilitation treatment; 3) to compare the ability of COM-SI and COMPL-SI to predict functional independence at discharge with that of w-CI.
METHODS: Eighty-five stroke rehabilitation inpatients participated in the study. The type, incidence and severity of COM at admission and of COMPL during the whole hospital stay were studied prospectively. The Functional Independence Measure (FIM) scale was administered at both admission and discharge.
RESULTS: About 1/3 suffered from some significant COM and another 1/3 developed COMPLs needing specific medical treatment and/or clinical monitoring. The most frequent COMs and COMPLs were cardiovascular and psychiatric/psychological diseases. The odds of having a high efficiency in the daily functional gain (FIM score) were greater for patients without any COM (3.5) and/or COMPL (4.6). Similarly, the odds of having a high FIM score at discharge were greater (3.5) for patients without COM or COMPL. The COM-SI demonstrated a higher predictive capacity of the FIM score at discharge (5%) than w-CI (4%), and COMPL-SI (1%).
CONCLUSIONS: COM-SI resulted as the most interesting predictive index of functional outcome at discharge, after accounting for the functional status at admission.

Entities:  

Mesh:

Year:  2006        PMID: 16767056

Source DB:  PubMed          Journal:  Eura Medicophys        ISSN: 0014-2573


  7 in total

1.  Effect of Comorbidities on Outcomes of Neurorehabilitation Interventions in Multiple Sclerosis: A Scoping Review.

Authors:  Afolasade Fakolade; Etienne J Bisson; Julie Pétrin; Julie Lamarre; Marcia Finlayson
Journal:  Int J MS Care       Date:  2016 Nov-Dec

2.  Comorbidity and intercurrent diseases in geriatric stroke rehabilitation: a multicentre observational study in skilled nursing facilities.

Authors:  Anouk D Kabboord; Monica Van Eijk; Bianca I Buijck; Raymond T C M Koopmans; Romke van Balen; Wilco P Achterberg
Journal:  Eur Geriatr Med       Date:  2018-03-13       Impact factor: 1.710

3.  Reliability and usability of a weighted version of the Functional Comorbidity Index.

Authors:  Anouk D Kabboord; Monica van Eijk; Lisette van Dingenen; Monique Wouters; Marieke Koet; Romke van Balen; Wilco P Achterberg
Journal:  Clin Interv Aging       Date:  2019-02-11       Impact factor: 4.458

4.  Prevalence, Patterns, and Predictors of Multimorbidity in Adults With Acquired Brain Injury at Admission to Staged Community-Based Rehabilitation.

Authors:  Hayley M Jackson; Lakkhina Troeung; Angelita Martini
Journal:  Arch Rehabil Res Clin Transl       Date:  2020-10-30

5.  Acute Inpatient Rehabilitation Improves Function Independent of Comorbidities in Medically Complex Patients.

Authors:  Shangming Zhang; Dan Lin; Megan E Wright; Nicole Swallow
Journal:  Arch Rehabil Res Clin Transl       Date:  2022-01-12

6.  The modified functional comorbidity index performed better than the Charlson index and original functional comorbidity index in predicting functional outcome in geriatric rehabilitation: a prospective observational study.

Authors:  Anouk D Kabboord; Deborah Godfrey; Adam L Gordon; John R F Gladman; Monica Van Eijk; Romke van Balen; Wilco P Achterberg
Journal:  BMC Geriatr       Date:  2020-03-29       Impact factor: 3.921

7.  New Index for Multiple Chronic Conditions Predicts Functional Outcome in Ischemic Stroke.

Authors:  Xiaqing Jiang; Lu Wang; Lewis B Morgenstern; Christine T Cigolle; Edward S Claflin; Lynda D Lisabeth
Journal:  Neurology       Date:  2020-10-06       Impact factor: 9.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.